Enzictra - DS Tablet
By Enzictra
Rx
10 Tablet in a Strip

Composition
Bromelain(180mg) + Trypsin(96mg) + Rutoside(200mg) + Papain(120mg)

Manufacturer - Alembic Pharmaceuticals Ltd
Alembic Road, Vadodara - 390 003, Gujarat,INDIA

Expires on or after
June, 2026

liver
Enzictra - DS Tablet is considered safe for patients with liver disease, based on the limited available data. It is believed that adjusting the dose of Enzictra - DS Tablet may not be necessary for individuals with liver issues. However, it is strongly advised to consult with your doctor before using this medication to ensure that it is safe and appropriate for your specific condition.

kidney
Enzictra - DS Tablet appears safe for kidney disease patients without needing dose adjustment. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Enzictra - DS Tablet.

driving
When taking Enzictra - DS Tablet, avoid driving if you notice any symptoms that impact your focus and reaction time. It is unclear if this medication affects driving ability. Be cautious and seek guidance from a healthcare professional if needed.

pregnancy
Information about the safety of using Enzictra - DS Tablet during pregnancy is not available. Please consult your doctor before using this medication.

breastfeeding
It is better to consult your doctor before using Enzictra - DS Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹568.3
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025